Eye Health Ingredients Market Size By Source (Natural, Synthetic), By Ingredient (Lutein, Zeaxanthin, Beta Carotene, Vitamin A, Bilberry Extracts), By Form (Soft gel, capsule & tablets, Liquid, Powder), By End Use (Human, Animal), By Disease Indication (Age related Macular Degeneration, Cataract, Dry Eye Syndrome), Industry Analysis Report, Regional Outlook, Application Potential, Price Trend, Competitive Market Share & Forecast, 2017 – 2024

Published Date: May 2017  |  Report ID: GMI1582  |  Authors: Kunal Ahuja, Amit Rawat

Report Format: PDF   |   Pages: 300   |   Base Year: 2016




Report Content

Chapter 1.  Methodology & Scope

1.1.  Methodology

1.1.1.   Initial data exploration

1.1.2.   Statistical model and forecast

1.1.3.   Industry insights and validation

1.1.4.   Definitions & forecast parameters

1.2.  Data sources

1.2.1.   Secondary

1.2.2.   Primary

Chapter 2.  Executive Summary

2.1.  Eye health ingredients market 3600 synopsis, 2013 –2024

2.1.1.   Business trends

2.1.2.   Source trends

2.1.3.   Ingredient trends

2.1.4.   Form trends

2.1.5.   Application trends

2.1.6.   Disease indication trends

2.1.7.   Regional trends

Chapter 3.  Eye Health Ingredients Industry Insights

3.1.  Industry segmentation

3.2.  Industry growth landscape, 2013 - 2024

3.3.  Industry ecosystem analysis

3.3.1.   Regional profit margin trends

3.3.1.1.   North America

3.3.1.2.   Europe

3.3.1.3.   APAC

3.3.1.4.   LATAM

3.3.1.5.   MEA

3.3.2.   Vendor matrix

3.3.2.1.   Raw material suppliers

3.3.2.2.   Ingredient manufacturers

3.3.2.3.   Geographical footprint

3.3.2.4.   Production capacity of key players

3.3.3.   Distribution channel analysis

3.3.3.1.   Supermarkets

3.3.3.2.   Specialty retail

3.3.3.3.   Pharmacy Chains

3.3.3.4.   Independent Retailers

3.3.3.5.   Internet/ home shopping

3.4.  Regional pricing trends

3.4.1.1.   North America

3.4.1.2.   Europe

3.4.1.3.   APAC

3.4.1.4.   LATAM

3.4.1.5.   MEA

3.5.  Trade scenario

3.6.  Regulatory landscape

3.6.1.   Regulation of Color Additives

3.6.1.1.   U.S.

3.6.1.2.   Europe

3.6.1.3.   China

3.6.1.4.   APAC

3.7.  Regional raw material trends

3.7.1.   Lutein

3.7.2.   Zeaxanthin

3.7.3.   Beta Carotene

3.7.4.   Vitamin A

3.7.5.   Bilberry extracts

3.7.6.   Others (Capsanthin, Annatto, Omega-3)

3.8.  Industry impact forces

3.8.1.   Growth drivers

3.8.1.1.   Increasing consumer concerns around eye health

3.8.1.2.   Nutraceutical industry expansion

3.8.1.3.   Increasing AMD disease occurrence among geriatric population

3.8.1.4.   Increase in healthcare expenditure leading consumer interest over OTC supplements

3.8.2.   Industry pitfalls & challenges

3.8.2.1.   Limited availability of lutein and zeaxanthin

3.8.2.2.   Harmful health effects from carotenoid consumption

3.9.  Eye health ingredients latest product launches

3.9.1.   U.S.

3.9.2.   Germany

3.9.3.   Russia

3.9.4.   India

3.9.5.   UK

3.9.6.   China

3.9.7.   Brazil

3.9.8.   South Africa

3.10.    Growth potential analysis, 2016

3.11.   Critical success factors

3.11.1.   Role of industry associations

3.11.2.   International demographics of declining vision

3.11.3.   Consumer behavior towards eye health ingredients

3.11.4.   OTC eye care supplements vs prescribed eyecare supplements

3.11.5.   Regional consumer insights

3.11.5.1.   North America

3.11.5.2.   Europe

3.11.5.3.   APAC

3.11.5.4.   LATAM

3.11.5.5.   MEA

3.12.    Porter's analysis

3.13.   Company market share analysis, 2016

3.13.1.   Strategy dashboard

3.14.    PESTEL analysis

Chapter 4.  Eye Health Ingredients Market, By Source

4.1.  Global eye health ingredients market share by source, 2016 & 2024

4.2.  Natural

4.2.1.   Market estimates and forecast, 2013 - 2024

4.2.2.   Market estimates and forecast, by region, 2013–2024

4.3.  Synthetic

4.3.1.   Market estimates and forecast, 2013 - 2024

4.3.2.   Market estimates and forecast, by region, 2013–2024

Chapter 5.  Eye Health Ingredients Market, By Ingredient

5.1.  Global eye health ingredients market share by ingredient, 2016 & 2024

5.2.  Lutein

5.2.1.   Market estimates and forecast, 2013 - 2024

5.2.2.   Market estimates and forecast, by region, 2013–2024

5.3.  Zeaxanthin

5.3.1.   Market estimates and forecast, 2013 - 2024

5.3.2.   Market estimates and forecast, by region, 2013–2024

5.4.  Beta Carotene

5.4.1.   Market estimates and forecast, 2013 - 2024

5.4.2.   Market estimates and forecast, by region, 2013–2024

5.5.  Vitamin A

5.5.1.   Market estimates and forecast, 2013 - 2024

5.5.2.   Market estimates and forecast, by region, 2013–2024

5.6.  Bilberry extracts

5.6.1.   Market estimates and forecast, 2013 - 2024

5.6.2.   Market estimates and forecast, by region, 2013–2024

5.7.  Others (Vitamin C, Vitamin E, Zinc & Omega-3 fatty acids, Astaxanthin)

5.7.1.   Market estimates and forecast, 2013 - 2024

5.7.2.   Market estimates and forecast, by region, 2013–2024

Chapter 6.  Eye Health Ingredients Market, By Form

6.1.  Global eye health ingredients market share by form, 2016 & 2024

6.2.  Soft gel, capsule & tablets

6.2.1.   Market estimates and forecast, 2013 - 2024

6.2.2.   Market estimates and forecast, by region, 2013–2024

6.3.  Liquid

6.3.1.   Market estimates and forecast, 2013 - 2024

6.3.2.   Market estimates and forecast, by region, 2013–2024

6.4.  Powder

6.4.1.   Market estimates and forecast, 2013 - 2024

6.4.2.   Market estimates and forecast, by region, 2013–2024

Chapter 7.  Eye Health Ingredients Market, By Application

7.1.  Global eye health ingredients market share by application, 2016 & 2024

7.2.  Human

7.2.1.   Market estimates and forecast, 2013 - 2024

7.2.2.   Market estimates and forecast, by region, 2013–2024

7.3.  Animal

7.3.1.   Market estimates and forecast, 2013 - 2024

7.3.2.   Market estimates and forecast, by region, 2013–2024

Chapter 8.  Eye Health Ingredients Market, By Disease Indication

8.1.  Global eye health ingredients market share by disease indication, 2016 & 2024

8.2.  Age related macular degeneration

8.2.1.   Market estimates and forecast, 2013 - 2024

8.2.2.   Market estimates and forecast, by region, 2013–2024

8.3.  Cataract

8.3.1.   Market estimates and forecast, 2013 - 2024

8.3.2.   Market estimates and forecast, by region, 2013–2024

8.4.  Dry eye syndrome

8.4.1.   Market estimates and forecast, 2013 - 2024

8.4.2.   Market estimates and forecast, by region, 2013–2024

8.5.  Other indications

8.5.1.   Market estimates and forecast, 2013 - 2024

8.5.2.   Market estimates and forecast, by region, 2013–2024

Chapter 9.  Eye Health Ingredients Market, By Region

9.1.  Global eye health ingredients market share by region, 2016 & 2024

9.2.  North America

9.2.1.   Market estimates and forecast, 2013 – 2024

9.2.2.   Market estimates and forecast, by source, 2013 – 2024

9.2.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.2.4.   Market estimates and forecast, by form, 2013 – 2024

9.2.5.   Market estimates and forecast, by application, 2013 – 2024

9.2.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.2.7.   U.S.

9.2.7.1.   Market estimates and forecast, 2013 – 2024

9.2.7.2.   Market estimates and forecast, by source, 2013 – 2024

9.2.7.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.2.7.4.   Market estimates and forecast, by form, 2013 – 2024

9.2.7.5.   Market estimates and forecast, by application, 2013 – 2024

9.2.7.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.2.8.   Canada

9.2.8.1.   Market estimates and forecast, 2013 – 2024

9.2.8.2.   Market estimates and forecast, by source, 2013 – 2024

9.2.8.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.2.8.4.   Market estimates and forecast, by form, 2013 – 2024

9.2.8.5.   Market estimates and forecast, by application, 2013 – 2024

9.2.8.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.3.  Europe

9.3.1.   Market estimates and forecast, 2013 – 2024

9.3.2.   Market estimates and forecast, by source, 2013 – 2024

9.3.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.3.4.   Market estimates and forecast, by form, 2013 – 2024

9.3.5.   Market estimates and forecast, by application, 2013 – 2024

9.3.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.3.7.   Germany

9.3.7.1.   Market estimates and forecast, 2013 – 2024

9.3.7.2.   Market estimates and forecast, by source, 2013 – 2024

9.3.7.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.3.7.4.   Market estimates and forecast, by form, 2013 – 2024

9.3.7.5.   Market estimates and forecast, by application, 2013 – 2024

9.3.7.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.3.8.   UK

9.3.8.1.   Market estimates and forecast, 2013 – 2024

9.3.8.2.   Market estimates and forecast, by source, 2013 – 2024

9.3.8.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.3.8.4.   Market estimates and forecast, by form, 2013 – 2024

9.3.8.5.   Market estimates and forecast, by application, 2013 – 2024

9.3.8.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.3.9.   France

9.3.9.1.   Market estimates and forecast, 2013 – 2024

9.3.9.2.   Market estimates and forecast, by source, 2013 – 2024

9.3.9.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.3.9.4.   Market estimates and forecast, by form, 2013 – 2024

9.3.9.5.   Market estimates and forecast, by application, 2013 – 2024

9.3.9.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.3.10.   Italy

9.3.10.1.   Market estimates and forecast, 2013 – 2024

9.3.10.2.   Market estimates and forecast, by source, 2013 – 2024

9.3.10.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.3.10.4.   Market estimates and forecast, by form, 2013 – 2024

9.3.10.5.   Market estimates and forecast, by application, 2013 – 2024

9.3.10.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.3.11.   Russia

9.3.11.1.   Market estimates and forecast, 2013 – 2024

9.3.11.2.   Market estimates and forecast, by source, 2013 – 2024

9.3.11.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.3.11.4.   Market estimates and forecast, by form, 2013 – 2024

9.3.11.5.   Market estimates and forecast, by application, 2013 – 2024

9.3.11.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.4.  Asia Pacific

9.4.1.   Market estimates and forecast, 2013 – 2024

9.4.2.   Market estimates and forecast, by source, 2013 – 2024

9.4.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.4.4.   Market estimates and forecast, by form, 2013 – 2024

9.4.5.   Market estimates and forecast, by application, 2013 – 2024

9.4.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.4.7.   China

9.4.7.1.   Market estimates and forecast, 2013 – 2024

9.4.7.2.   Market estimates and forecast, by source, 2013 – 2024

9.4.7.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.4.7.4.   Market estimates and forecast, by form, 2013 – 2024

9.4.7.5.   Market estimates and forecast, by application, 2013 – 2024

9.4.7.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.4.8.   India

9.4.8.1.   Market estimates and forecast, 2013 – 2024

9.4.8.2.   Market estimates and forecast, by source, 2013 – 2024

9.4.8.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.4.8.4.   Market estimates and forecast, by form, 2013 – 2024

9.4.8.5.   Market estimates and forecast, by application, 2013 – 2024

9.4.8.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.4.9.   South Korea

9.4.9.1.   Market estimates and forecast, 2013 – 2024

9.4.9.2.   Market estimates and forecast, by source, 2013 – 2024

9.4.9.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.4.9.4.   Market estimates and forecast, by form, 2013 – 2024

9.4.9.5.   Market estimates and forecast, by application, 2013 – 2024

9.4.9.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.4.10.   Japan

9.4.10.1.   Market estimates and forecast, 2013 – 2024

9.4.10.2.   Market estimates and forecast, by source, 2013 – 2024

9.4.10.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.4.10.4.   Market estimates and forecast, by form, 2013 – 2024

9.4.10.5.   Market estimates and forecast, by application, 2013 – 2024

9.4.10.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.5.  Latin America

9.5.1.   Market estimates and forecast, 2013 – 2024

9.5.2.   Market estimates and forecast, by source, 2013 – 2024

9.5.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.5.4.   Market estimates and forecast, by form, 2013 – 2024

9.5.5.   Market estimates and forecast, by application, 2013 – 2024

9.5.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.5.7.   Brazil

9.5.7.1.   Market estimates and forecast, 2013 – 2024

9.5.7.2.   Market estimates and forecast, by source, 2013 – 2024

9.5.7.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.5.7.4.   Market estimates and forecast, by form, 2013 – 2024

9.5.7.5.   Market estimates and forecast, by application, 2013 – 2024

9.5.7.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.5.8.   Mexico

9.5.8.1.   Market estimates and forecast, 2013 – 2024

9.5.8.2.   Market estimates and forecast, by source, 2013 – 2024

9.5.8.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.5.8.4.   Market estimates and forecast, by form, 2013 – 2024

9.5.8.5.   Market estimates and forecast, by application, 2013 – 2024

9.5.8.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.5.9.   Argentina

9.5.9.1.   Market estimates and forecast, 2013 – 2024

9.5.9.2.   Market estimates and forecast, by source, 2013 – 2024

9.5.9.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.5.9.4.   Market estimates and forecast, by form, 2013 – 2024

9.5.9.5.   Market estimates and forecast, by application, 2013 – 2024

9.5.9.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.6.  Middle East & Africa (MEA)

9.6.1.   Market estimates and forecast, 2013 – 2024

9.6.2.   Market estimates and forecast, by source, 2013 – 2024

9.6.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.6.4.   Market estimates and forecast, by form, 2013 – 2024

9.6.5.   Market estimates and forecast, by application, 2013 – 2024

9.6.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.6.7.   Saudi Arabia

9.6.7.1.   Market estimates and forecast, 2013 – 2024

9.6.7.2.   Market estimates and forecast, by source, 2013 – 2024

9.6.7.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.6.7.4.   Market estimates and forecast, by form, 2013 – 2024

9.6.7.5.   Market estimates and forecast, by application, 2013 – 2024

9.6.7.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.6.8.   UAE

9.6.8.1.   Market estimates and forecast, 2013 – 2024

9.6.8.2.   Market estimates and forecast, by source, 2013 – 2024

9.6.8.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.6.8.4.   Market estimates and forecast, by form, 2013 – 2024

9.6.8.5.   Market estimates and forecast, by application, 2013 – 2024

9.6.8.6.   Market estimates and forecast, by disease indication, 2013 – 2024

9.6.9.   South Africa

9.6.9.1.   Market estimates and forecast, 2013 – 2024

9.6.9.2.   Market estimates and forecast, by source, 2013 – 2024

9.6.9.3.   Market estimates and forecast, by ingredient, 2013 – 2024

9.6.9.4.   Market estimates and forecast, by form, 2013 – 2024

9.6.9.5.   Market estimates and forecast, by application, 2013 – 2024

9.6.9.6.   Market estimates and forecast, by disease indication, 2013 – 2024

Chapter 10.   Company Profiles

10.1.    Allied Biotech Corporation

10.1.1.   Business Overview

10.1.2.   Financial Data

10.1.3.   Concentrations Landscape

10.1.4.   Strategic Outlook

10.1.5.   SWOT Analysis

10.2.    BASF

10.2.1.   Business Overview

10.2.2.   Financial Data

10.2.3.   Concentrations Landscape

10.2.4.   Strategic Outlook

10.2.5.   SWOT Analysis

10.3.    DSM

10.3.1.   Business Overview

10.3.2.   Financial Data

10.3.3.   Concentrations Landscape

10.3.4.   Strategic Outlook

10.3.5.   SWOT Analysis

10.4.    Kemin

10.4.1.   Business Overview

10.4.2.   Financial Data

10.4.3.   Concentrations Landscape

10.4.4.   Strategic Outlook

10.4.5.   SWOT Analysis

10.5.    Tianjin Pharmaland Technology

10.5.1.   Business Overview

10.5.2.   Financial Data

10.5.3.   Concentrations Landscape

10.5.4.   Strategic Outlook

10.5.5.   SWOT Analysis

10.6.    American River Nutrition, Inc

10.6.1.   Business Overview

10.6.2.   Financial Data

10.6.3.   Concentrations Landscape

10.6.4.   Strategic Outlook

10.6.5.   SWOT Analysis

10.7.    Archer Daniels Midland Company

10.7.1.   Business Overview

10.7.2.   Financial Data

10.7.3.   Concentrations Landscape

10.7.4.   Strategic Outlook

10.7.5.   SWOT Analysis

10.8.    Vitae Naturals

10.8.1.   Business Overview

10.8.2.   Financial Data

10.8.3.   Concentrations Landscape

10.8.4.   Strategic Outlook

10.8.5.   SWOT Analysis

10.9.    Davos life Science

10.9.1.   Business Overview

10.9.2.   Financial Data

10.9.3.   Concentrations Landscape

10.9.4.   Strategic Outlook

10.9.5.   SWOT Analysis

10.10.   Cargil

10.10.1.   Business Overview

10.10.2.   Financial Data

10.10.3.   Concentrations Landscape

10.10.4.   Strategic Outlook

10.10.5.   SWOT Analysis

10.11.   Wilmer Spring Fruit Nutrition Products Co. Ltd

10.11.1.   Business Overview

10.11.2.   Financial Data

10.11.3.   Concentrations Landscape

10.11.4.   Strategic Outlook

10.11.5.   SWOT Analysis

10.12.   FMC corporation

10.12.1.   Business Overview

10.12.2.   Financial Data

10.12.3.   Concentrations Landscape

10.12.4.   Strategic Outlook

10.12.5.   SWOT Analysis

10.13.   Vidya Europe SAS

10.13.1.   Business Overview

10.13.2.   Financial Data

10.13.3.   Concentrations Landscape

10.13.4.   Strategic Outlook

10.13.5.   SWOT Analysis

Chapter 11.   Potential Customer Profiles

11.1.    Amway

11.1.1.   Business Overview

11.1.2.   Financial Data

11.1.3.   Concentrations Landscape

11.1.4.   Strategic Outlook

11.2.    Solgar

11.2.1.   Business Overview

11.2.2.   Financial Data

11.2.3.   Concentrations Landscape

11.2.4.   Strategic Outlook

11.3.    Life extension

11.3.1.   Business Overview

11.3.2.   Financial Data

11.3.3.   Concentrations Landscape

11.3.4.   Strategic Outlook

11.4.    Jarrow Formulas

11.4.1.   Business Overview

11.4.2.   Financial Data

11.4.3.   Concentrations Landscape

11.4.4.   Strategic Outlook

11.5.    NOW Foods

11.5.1.   Business Overview

11.5.2.   Financial Data

11.5.3.   Concentrations Landscape

11.5.4.   Strategic Outlook

11.6.    Natures’s Life

11.6.1.   Business Overview

11.6.2.   Financial Data

11.6.3.   Concentrations Landscape

11.6.4.   Strategic Outlook

11.7.    Nutrovea

11.7.1.   Business Overview

11.7.2.   Financial Data

11.7.3.   Concentrations Landscape

11.7.4.   Strategic Outlook

11.8.    Natures Lab

11.8.1.   Business Overview

11.8.2.   Financial Data

11.8.3.   Concentrations Landscape

11.8.4.   Strategic Outlook

11.9.    Zenith Nutrition

11.9.1.   Business Overview

11.9.2.   Financial Data

11.9.3.   Concentrations Landscape

11.9.4.   Strategic Outlook

11.10.   Blubonnet Nutrition

11.10.1.   Business Overview

11.10.2.   Financial Data

11.10.3.   Concentrations Landscape

11.10.4.   Strategic Outlook

11.11.   Sirulina

11.11.1.   Business Overview

11.11.2.   Financial Data

11.11.3.   Concentrations Landscape

11.11.4.   Strategic Outlook

11.12.   Caps Extra

11.12.1.   Business Overview

11.12.2.   Financial Data

11.12.3.   Concentrations Landscape

11.12.4.   Strategic Outlook

11.13.   MacuShield

11.13.1.   Business Overview

11.13.2.   Financial Data

11.13.3.   Concentrations Landscape

11.13.4.   Strategic Outlook

11.14.   PreserVision

11.14.1.   Business Overview

11.14.2.   Financial Data

11.14.3.   Concentrations Landscape

11.14.4.   Strategic Outlook

11.15.   Efalex

11.15.1.   Business Overview

11.15.2.   Financial Data

11.15.3.   Concentrations Landscape

11.15.4.   Strategic Outlook

11.16.   BioCare NutriGuard

11.16.1.   Business Overview

11.16.2.   Financial Data

11.16.3.   Concentrations Landscape

11.16.4.   Strategic Outlook

11.17.   Futurebiotics

11.17.1.   Business Overview

11.17.2.   Financial Data

11.17.3.   Concentrations Landscape

11.17.4.   Strategic Outlook

11.18.   Swanson Products

11.18.1.   Business Overview

11.18.2.   Financial Data

11.18.3.   Concentrations Landscape

11.18.4.   Strategic Outlook

11.19.   Davis Vision

11.19.1.   Business Overview

11.19.2.   Financial Data

11.19.3.   Concentrations Landscape

11.19.4.   Strategic Outlook

11.20.   Alcon

11.20.1.   Business Overview

11.20.2.   Financial Data

11.20.3.   Concentrations Landscape

11.20.4.   Strategic Outlook

11.21.   Pfizer Inc.

11.21.1.   Business Overview

11.21.2.   Financial Data

11.21.3.   Concentrations Landscape

11.21.4.   Strategic Outlook

11.22.   Vitabiotics Ltd.

11.22.1.   Business Overview

11.22.2.   Financial Data

11.22.3.   Concentrations Landscape

11.22.4.   Strategic Outlook

11.23.   Valeant Pharmaceuticals International Inc.

11.23.1.   Business Overview

11.23.2.   Financial Data

11.23.3.   Concentrations Landscape

11.23.4.   Strategic Outlook

11.24.   Alliance Pharma

11.24.1.   Business Overview

11.24.2.   Financial Data

11.24.3.   Concentrations Landscape

11.24.4.   Strategic Outlook

11.25.   The Nature's Bounty Co

11.25.1.   Business Overview

11.25.2.   Financial Data

11.25.3.   Concentrations Landscape

11.25.4.   Strategic Outlook

11.26.   Novartis AG

11.26.1.   Business Overview

11.26.2.   Financial Data

11.26.3.   Concentrations Landscape

11.26.4.   Strategic Outlook

 

Data Tables

TABLE 1             Eye health ingredients industry 3600 synopsis, 2013 - 2024

TABLE 2             Global eye health ingredients market, 2013 - 2024, (Tons) (Revenue)

TABLE 3             Global market estimates by region, 2013 - 2024 (Tons) (Revenue)

TABLE 4             Global market estimates by source, 2013 - 2024 (Tons) (Revenue)

TABLE 5             Global market estimates by ingredient, 2013 - 2024 (Tons) (Revenue)

TABLE 6             Global market estimates by form, 2013 - 2024 (Tons) (Revenue)

TABLE 7             Global market estimates by application, 2013 - 2024 (Tons) (Revenue)

TABLE 8             Global market estimates by disease indication, 2013 - 2024 (Tons) (Revenue)

TABLE 9             Industry ecosystem analysis

TABLE 10           Growth drivers

TABLE 11           Industry pitfalls & challenges

TABLE 12           Natural eye health ingredients market estimates and forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 13           Natural eye health ingredients market estimates and forecast by region, 2013– 2024, (Tons)

TABLE 14           Natural eye health ingredients market estimates and forecast by region, 2013– 2024, (USD Million)

TABLE 15           Synthetic eye health ingredients market estimates and forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 16           Synthetic eye health ingredients market estimates and forecast by region, 2013– 2024, (Tons)

TABLE 17           Synthetic eye health ingredients market estimates and forecast by region, 2013– 2024, (USD Million)

TABLE 18           Lutein eye health ingredients market estimates and forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 19           Lutein eye health ingredients market estimates and forecast by region, 2013– 2024, (Tons)

TABLE 20           Lutein eye health ingredients market estimates and forecast by region, 2013– 2024, (USD Million)

TABLE 21           Zeaxanthin eye health ingredients market estimates and forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 22           Zeaxanthin eye health ingredients market estimates and forecast by region, 2013– 2024, (Tons)

TABLE 23           Zeaxanthin eye health ingredients market estimates and forecast by region, 2013– 2024, (USD Million)

TABLE 24           Beta Carotene eye health ingredients market estimates and forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 25           Beta Carotene eye health ingredients market estimates and forecast by region, 2013– 2024, (Tons)

TABLE 26           Beta Carotene eye health ingredients market estimates and forecast by region, 2013– 2024, (USD Million)

TABLE 27           Vitamin A eye health ingredients market estimates and forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 28           Vitamin A eye health ingredients market estimates and forecast by region, 2013– 2024, (Tons)

TABLE 29           Vitamin A eye health ingredients market estimates and forecast by region, 2013– 2024, (USD Million)

TABLE 30           Bilberry extracts eye health ingredients market estimates and forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 31           Bilberry extracts eye health ingredients market estimates and forecast by region, 2013– 2024, (Tons)

TABLE 32           Bilberry extracts eye health ingredients market estimates and forecast by region, 2013– 2024, (USD Million)

TABLE 33           Eye health ingredients market estimates and forecast from other products, 2013 – 2024, (Tons) (USD Million)

TABLE 34           Eye health ingredients market estimates and forecast from other ingredients by region, 2013– 2024, (Tons)

TABLE 35           Eye health ingredients market estimates and forecast from other ingredients by region, 2013– 2024, (USD Million)

TABLE 36           Eye health ingredients market estimates and forecast from soft gel, capsule & tablets, 2013 – 2024, (Tons) (USD Million)

TABLE 37           Eye health ingredients market estimates and forecast from soft gel, capsule & tablets by region, 2013– 2024, (Tons)

TABLE 38           Eye health ingredients market estimates and forecast from soft gel, capsule & tablets by region, 2013– 2024, (USD Million)

TABLE 39           Eye health ingredients market estimates and forecast from liquid, 2013 – 2024, (Tons) (USD Million)

TABLE 40           Eye health ingredients market estimates and forecast from liquid by region, 2013– 2024, (Tons)

TABLE 41           Eye health ingredients market estimates and forecast from liquid by region, 2013– 2024, (USD Million)

TABLE 42           Eye health ingredients market estimates and forecast from powder, 2013 – 2024, (Tons) (USD Million)

TABLE 43           Eye health ingredients market estimates and forecast from powder by region, 2013– 2024, (Tons)

TABLE 44           Eye health ingredients market estimates and forecast from powder by region, 2013– 2024, (USD Million)

TABLE 45           Eye health ingredients market estimates and forecast from human, 2013 – 2024, (Tons) (USD Million)

TABLE 46           Eye health ingredients market estimates and forecast from human by region, 2013– 2024, (Tons)

TABLE 47           Eye health ingredients market estimates and forecast from human by region, 2013– 2024, (USD Million)

TABLE 48           Eye health ingredients market estimates and forecast from animal, 2013 – 2024, (Tons) (USD Million)

TABLE 49           Eye health ingredients market estimates and forecast from animal by region, 2013– 2024, (Tons)

TABLE 50           Eye health ingredients market estimates and forecast from animal by region, 2013– 2024, (USD Million)

TABLE 51           Eye health ingredients market estimates and forecast from age related macular degeneration, 2013 – 2024, (Tons) (USD Million)

TABLE 52           Eye health ingredients market estimates and forecast from age related macular degeneration by region, 2013– 2024, (Tons)

TABLE 53           Eye health ingredients market estimates and forecast from age related macular degeneration by region, 2013– 2024, (USD Million)

TABLE 54           Eye health ingredients market estimates and forecast from cataract, 2013 – 2024, (Tons) (USD Million)

TABLE 55           Eye health ingredients market estimates and forecast from cataract by region, 2013– 2024, (Tons)

TABLE 56           Eye health ingredients market estimates and forecast from cataract by region, 2013– 2024, (USD Million)

TABLE 57           Eye health ingredients market estimates and forecast from dry eye syndrome, 2013 – 2024, (Tons) (USD Million)

TABLE 58           Eye health ingredients market estimates and forecast from dry eye syndrome by region, 2013– 2024, (Tons)

TABLE 59           Eye health ingredients market estimates and forecast from dry eye syndrome by region, 2013– 2024, (USD Million)

TABLE 60           Eye health ingredients market estimates and forecast from other indications, 2013 – 2024, (Tons) (USD Million)

TABLE 61           Eye health ingredients market estimates and forecast from other indications by region, 2013– 2024, (Tons)

TABLE 62           Eye health ingredients market estimates and forecast from other indications by region, 2013– 2024, (USD Million)

TABLE 63           North America market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 64           North America market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 65           North America market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 66           North America market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 67           North America market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 68           North America market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 69           North America market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 70           North America market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 71           North America market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 72           North America market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 73           North America market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 74           U.S. market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 75           U.S. market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 76           U.S. market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 77           U.S. market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 78           U.S. market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 79           U.S. market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 80           U.S. market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 81           U.S. market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 82           U.S. market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 83           U.S. market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 84           U.S. market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 85           Canada market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 86           Canada market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 87           Canada market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 88           Canada market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 89           Canada market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 90           Canada market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 91           Canada market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 92           Canada market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 93           Canada market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 94           Canada market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 95           Canada market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 96           Europe market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 97           Europe market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 98           Europe market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 99           Europe market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 100        Europe market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 101        Europe market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 102        Europe market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 103        Europe market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 104        Europe market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 105        Europe market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 106        Europe market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 107        Germany market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 108        Germany market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 109        Germany market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 110        Germany market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 111        Germany market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 112        Germany market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 113        Germany market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 114        Germany market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 115        Germany market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 116        Germany market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 117        Germany market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 118        UK market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 119        UK market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 120        UK market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 121        UK market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 122        UK market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 123        UK market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 124        UK market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 125        UK market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 126        UK market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 127        UK market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 128        UK market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 129        France market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 130        France market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 131        France market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 132        France market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 133        France market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 134        France market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 135        France market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 136        France market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 137        France market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 138        France market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 139        France market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 140        Poland market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 141        Poland market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 142        Poland market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 143        Poland market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 144        Poland market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 145        Poland market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 146        Poland market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 147        Poland market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 148        Poland market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 149        Poland market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 150        Poland market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 151        Russia market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 152        Russia market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 153        Russia market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 154        Russia market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 155        Russia market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 156        Russia market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 157        Russia market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 158        Russia market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 159        Russia market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 160        Russia market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 161        Russia market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 162        Asia Pacific market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 163        Asia Pacific market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 164        Asia Pacific market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 165        Asia Pacific market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 166        Asia Pacific market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 167        Asia Pacific market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 168        Asia Pacific market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 169        Asia Pacific market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 170        Asia Pacific market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 171        Asia Pacific market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 172        Asia Pacific market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 173        China market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 174        China market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 175        China market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 176        China market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 177        China market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 178        China market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 179        China market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 180        China market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 181        China market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 182        China market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 183        China market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 184        India market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 185        India market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 186        India market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 187        India market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 188        India market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 189        India market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 190        India market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 191        India market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 192        India market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 193        India market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 194        India market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 195        Japan market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 196        Japan market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 197        Japan market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 198        Japan market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 199        Japan market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 200        Japan market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 201        Japan market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 202        Japan market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 203        Japan market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 204        Japan market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 205        Japan market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 206        Indonesia market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 207        Indonesia market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 208        Indonesia market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 209        Indonesia market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 210        Indonesia market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 211        Indonesia market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 212        Indonesia market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 213        Indonesia market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 214        Indonesia market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 215        Indonesia market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 216        Indonesia market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 217        Thailand market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 218        Thailand market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 219        Thailand market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 220        Thailand market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 221        Thailand market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 222        Thailand market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 223        Thailand market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 224        Thailand market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 225        Thailand market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 226        Thailand market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 227        Thailand market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 228        Latin America market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 229        Latin America market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 230        Latin America market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 231        Latin America market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 232        Latin America market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 233        Latin America market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 234        Latin America market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 235        Latin America market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 236        Latin America market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 237        Latin America market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 238        Latin America market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 239        Brazil market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 240        Brazil market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 241        Brazil market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 242        Brazil market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 243        Brazil market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 244        Brazil market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 245        Brazil market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 246        Brazil market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 247        Brazil market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 248        Brazil market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 249        Brazil market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 250        Mexico market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 251        Mexico market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 252        Mexico market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 253        Mexico market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 254        Mexico market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 255        Mexico market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 256        Mexico market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 257        Mexico market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 258        Mexico market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 259        Mexico market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 260        Mexico market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 261        Argentina market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 262        Argentina market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 263        Argentina market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 264        Argentina market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 265        Argentina market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 266        Argentina market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 267        Argentina market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 268        Argentina market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 269        Argentina market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 270        Argentina market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 271        Argentina market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 272        Middle East & Africa market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 273        Middle East & Africa market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 274        Middle East & Africa market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 275        Middle East & Africa market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 276        Middle East & Africa market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 277        Middle East & Africa market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 278        Middle East & Africa market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 279        Middle East & Africa market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 280        Middle East & Africa market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 281        Middle East & Africa market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 282        Middle East & Africa market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 283        Saudi Arabia market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 284        Saudi Arabia market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 285        Saudi Arabia market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 286        Saudi Arabia market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 287        Saudi Arabia market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 288        Saudi Arabia market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 289        Saudi Arabia market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 290        Saudi Arabia market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 291        Saudi Arabia market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 292        Saudi Arabia market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 293        Saudi Arabia market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 294        UAE market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 295        UAE market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 296        UAE market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 297        UAE market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 298        UAE market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 299        UAE market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 300        UAE market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 301        UAE market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 302        UAE market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 303        UAE market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 304        UAE market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

TABLE 305        South Africa market estimates & forecast, 2013 – 2024, (Tons) (USD Million)

TABLE 306        South Africa market volume estimates & forecast, by source, 2013– 2024, (Tons)

TABLE 307        South Africa market revenue estimates & forecast, by source, 2013– 2024, (USD Million)

TABLE 308        South Africa market volume estimates & forecast, by ingredient, 2013– 2024, (Tons)

TABLE 309        South Africa market revenue estimates & forecast, by ingredient, 2013– 2024, (USD Million)

TABLE 310        South Africa market volume estimates & forecast, by form, 2013– 2024, (Tons)

TABLE 311        South Africa market revenue estimates & forecast, by form, 2013– 2024, (USD Million)

TABLE 312        South Africa market volume estimates & forecast, by application, 2013– 2024, (Tons)

TABLE 313        South Africa market revenue estimates & forecast, by application, 2013– 2024, (USD Million)

TABLE 314        South Africa market volume estimates & forecast, by disease indication, 2013– 2024, (Tons)

TABLE 315        South Africa market revenue estimates & forecast, by disease indication, 2013– 2024, (USD Million)

 

Charts & Figures

FIG. 1             Industry segmentation

FIG. 2             Global eye health ingredients market, 2013 - 2024 (USD Million)

FIG. 3             Industry ecosystem analysis

FIG. 4             Industry impact forces

FIG. 5             Growth potential analysis

FIG. 6             Competitive landscape, 2016

FIG. 7             Porter’s analysis

FIG. 8             PESTEL analysis

FIG. 9             Global eye health ingredients market share by source, 2016 & 2024

FIG. 10           Global eye health ingredients market share by ingredient, 2016 & 2024

FIG. 11           Global eye health ingredients market share by form, 2016 & 2024

FIG. 12           Global eye health ingredients market share by end-use, 2016 & 2024

FIG. 13           Global eye health ingredients market share by disease indication, 2016 & 2024

FIG. 14           Global eye health ingredients market share by region, 2016 & 2024

 

Premium Report Details

  • Published Date: May 2017
  • Pages: 300
  • Tables: 315
  • Charts / Figures: 14
  • Companies covered: 39
  • Countries covered: 24

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X